170 related articles for article (PubMed ID: 29658052)
1. Reduced αGlcNAc glycosylation on gastric gland mucin is a biomarker of malignant potential for gastric cancer, Barrett's adenocarcinoma, and pancreatic cancer.
Yamanoi K; Nakayama J
Histochem Cell Biol; 2018 Jun; 149(6):569-575. PubMed ID: 29658052
[TBL] [Abstract][Full Text] [Related]
2. Gastric gland mucin-specific O-glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer.
Ohya A; Yamanoi K; Shimojo H; Fujii C; Nakayama J
Cancer Sci; 2017 Sep; 108(9):1897-1902. PubMed ID: 28685935
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of gastric gland mucin-specific glycan α1,4-linked N-acetylglucosamine on its scaffold mucin 6 is associated with malignant potential of pyloric gland adenoma of the stomach.
Yamanoi K; Sekine S; Higuchi K; Kushima R; Nakayama J
Histopathology; 2015 Dec; 67(6):898-904. PubMed ID: 25929994
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma--a possible biomarker to predict the malignant potential of Barrett's oesophagus.
Iwaya Y; Hasebe O; Koide N; Kitahara K; Suga T; Shinji A; Muraki T; Yokosawa S; Yamada S; Arakura N; Tanaka E; Nakayama J
Histopathology; 2014 Mar; 64(4):536-46. PubMed ID: 24117499
[TBL] [Abstract][Full Text] [Related]
5. Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach.
Yamada S; Okamura T; Kobayashi S; Tanaka E; Nakayama J
J Gastroenterol Hepatol; 2015 Oct; 30(10):1478-84. PubMed ID: 25967588
[TBL] [Abstract][Full Text] [Related]
6. Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.
Shiratsu K; Higuchi K; Nakayama J
Cancer Sci; 2014 Jan; 105(1):126-33. PubMed ID: 24138592
[TBL] [Abstract][Full Text] [Related]
7. Diffuse MIST1 expression and decreased α1,4-linked N-acetylglucosamine (αGlcNAc) glycosylation on MUC6 are distinct hallmarks for gastric neoplasms showing oxyntic gland differentiation.
Yamada S; Yamanoi K; Sato Y; Nakayama J
Histopathology; 2020 Sep; 77(3):413-422. PubMed ID: 32502322
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation of MUC6 by α1,4-linked N-acetylglucosamine enhances suppression of pancreatic cancer malignancy.
Yuki A; Fujii C; Yamanoi K; Matoba H; Harumiya S; Kawakubo M; Nakayama J
Cancer Sci; 2022 Feb; 113(2):576-586. PubMed ID: 34808019
[TBL] [Abstract][Full Text] [Related]
9. Decreased alpha-1,4-linked N-acetylglucosamine glycosylation in biliary tract cancer progression from biliary intraepithelial neoplasia to invasive adenocarcinoma.
Okumura M; Yamanoi K; Uehara T; Nakayama J
Cancer Sci; 2020 Dec; 111(12):4629-4635. PubMed ID: 33020993
[TBL] [Abstract][Full Text] [Related]
10. Essential role of gastric gland mucin in preventing gastric cancer in mice.
Karasawa F; Shiota A; Goso Y; Kobayashi M; Sato Y; Masumoto J; Fujiwara M; Yokosawa S; Muraki T; Miyagawa S; Ueda M; Fukuda MN; Fukuda M; Ishihara K; Nakayama J
J Clin Invest; 2012 Mar; 122(3):923-34. PubMed ID: 22307328
[TBL] [Abstract][Full Text] [Related]
11. Dual Roles of Gastric Gland Mucin-specific O-glycans in Prevention of Gastric Cancer.
Nakayama J
Acta Histochem Cytochem; 2014 Feb; 47(1):1-9. PubMed ID: 24761044
[TBL] [Abstract][Full Text] [Related]
12. α1,4-Linked N-acetylglucosamine suppresses gastric cancer development by inhibiting Mucin-1-mediated signaling.
Fujii C; Harumiya S; Sato Y; Kawakubo M; Matoba H; Nakayama J
Cancer Sci; 2022 Nov; 113(11):3852-3863. PubMed ID: 35959971
[TBL] [Abstract][Full Text] [Related]
13. Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type.
Yamanoi K; Ishii K; Tsukamoto M; Asaka S; Nakayama J
Virchows Arch; 2018 Sep; 473(3):305-311. PubMed ID: 29845361
[TBL] [Abstract][Full Text] [Related]
14. MUC6 expression is a preferable prognostic marker for invasive mucinous adenocarcinoma of the lung.
Yamanoi K; Fujii C; Yuzuriha H; Kumazawa M; Shimoda M; Emoto K; Asamura H; Nakayama J
Histochem Cell Biol; 2022 Jun; 157(6):671-684. PubMed ID: 35353213
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of TFF2 and decreased αGlcNAc glycosylation are malignant biomarkers of pyloric gland adenoma of the duodenum.
Yamanoi K; Fujii C; Nakayama A; Matsuura N; Takatori Y; Kato M; Yahagi N; Nakayama J
Sci Rep; 2023 Dec; 13(1):21641. PubMed ID: 38062108
[TBL] [Abstract][Full Text] [Related]
16. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection up-regulates gland mucous cell-type mucins in gastric pyloric mucosa.
Matsuzwa M; Ota H; Hayama M; Zhang MX; Sano K; Honda T; Ueno I; Akamatsu T; Nakayama J
Helicobacter; 2003 Dec; 8(6):594-600. PubMed ID: 14632674
[TBL] [Abstract][Full Text] [Related]
18. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
[TBL] [Abstract][Full Text] [Related]
19. αGlcNAc and its catalyst α4GnT are diagnostic and prognostic markers in uterine cervical tumor, gastric type.
Ida K; Yamanoi K; Asaka S; Takeuchi H; Miyamoto T; Shiozawa T; Nakayama J
Sci Rep; 2019 Sep; 9(1):13043. PubMed ID: 31506488
[TBL] [Abstract][Full Text] [Related]
20. Decreased Gastric Gland Mucin-specific
Ohya A; Matoba H; Fujinaga Y; Nakayama J
Acta Histochem Cytochem; 2021 Aug; 54(4):115-122. PubMed ID: 34511650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
